上颌窦癌是常见的头颈部恶性肿瘤之一,由于上颌窦的局部解剖关系复杂以及发现较晚,致使各种疗法的疗效较差,据报告5年生存率为30.2～43.6%。日本的鼻和鼻窦癌发病率居世界第一位,面上颌窦癌占鼻、鼻窦恶性肿瘤的91%左右,其中鳞癌占80%。近年,日本对上颌窦癌盛行综合治疗,疗效显著提高,5年生存率可达78.4%,处于领先地位。兹就其综合治疗进展作一概括介绍。 Maxillary sinus cancer is one of the most common malignancies of the head and neck. Due to the complex anatomy of the maxillary sinus and the late discovery, the curative effect of various therapies is poor. It is reported that the 5-year survival rate is 30.2 to 43.6%. The incidence of nasal and sinus cancer in Japan ranks first in the world, and the maxillary sinus cancer accounts for about 91% of malignant tumors of the nose and sinuses, of which squamous cell carcinoma accounts for 80%. In recent years, Japan’s comprehensive treatment for maxillary sinus cancer has become more effective, with a 5-year survival rate of 78.4%. It gives an overview of the progress of its comprehensive treatment.